272 related articles for article (PubMed ID: 1686813)
1. Motor activity following the administration of selective D-1 and D-2 dopaminergic drugs to normal common marmosets.
Löschmann PA; Smith LA; Lange KW; Jaehnig P; Jenner P; Marsden CD
Psychopharmacology (Berl); 1991; 105(3):303-9. PubMed ID: 1686813
[TBL] [Abstract][Full Text] [Related]
2. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.
LaHoste GJ; Marshall JF
Behav Brain Res; 1990 May; 38(3):233-42. PubMed ID: 1973041
[TBL] [Abstract][Full Text] [Related]
3. Motor activity following the administration of selective D-1 and D-2 dopaminergic drugs to MPTP-treated common marmosets.
Löschmann PA; Smith LA; Lange KW; Jähnig P; Jenner P; Marsden CD
Psychopharmacology (Berl); 1992; 109(1-2):49-56. PubMed ID: 1365671
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole.
Zhou LW; Qin ZH; Weiss B
Neuropsychopharmacology; 1991 Jan; 4(1):47-55. PubMed ID: 1672250
[TBL] [Abstract][Full Text] [Related]
5. Behavioural effects of selective dopamine D-1 and D-2 agonists and antagonists in guinea-pigs.
Brent PJ
Psychopharmacology (Berl); 1991; 104(2):201-7. PubMed ID: 1831560
[TBL] [Abstract][Full Text] [Related]
6. The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum.
Delfs JM; Kelley AE
Neuroscience; 1990; 39(1):59-67. PubMed ID: 1982467
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of dopamine agonists on locomotion in intact and reserpine-treated mice.
Zarrindast MR; Eliassi A
Gen Pharmacol; 1991; 22(6):1027-31. PubMed ID: 1687393
[TBL] [Abstract][Full Text] [Related]
8. Effect of D1 and D2 agonists in primates withdrawn from long-term treatment with haloperidol: the potential role of dopamine D1 receptors in dyskinesia.
Lublin H; Gerlach J; Peacock L
Clin Neuropharmacol; 1992 Dec; 15(6):448-58. PubMed ID: 1362136
[TBL] [Abstract][Full Text] [Related]
9. Alpha 1 (but not alpha 2)-adrenoceptor agonists in combination with the dopamine D2 agonist quinpirole produce locomotor stimulation in dopamine-depleted mice.
Eshel G; Ross SB; Kelder D; Edis LE; Jackson DM
Pharmacol Toxicol; 1990 Aug; 67(2):123-31. PubMed ID: 1979437
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the interaction between D1 and D2 receptors in a drug discrimination paradigm.
Williams JE; Sutherland JV; Woolverton WL
Behav Neural Biol; 1990 May; 53(3):378-92. PubMed ID: 1972014
[TBL] [Abstract][Full Text] [Related]
11. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
Weick BG; Walters JR
Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
[TBL] [Abstract][Full Text] [Related]
12. Effects of daily SKF 38393, quinpirole, and SCH 23390 treatments on locomotor activity and subsequent sensitivity to apomorphine.
Mattingly BA; Rowlett JK; Lovell G
Psychopharmacology (Berl); 1993; 110(3):320-6. PubMed ID: 7831425
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of dopamine D-1 and D-2 receptor agonists on EEG activity and behaviour in the rabbit.
Ongini E; Caporali MG
Neuropharmacology; 1987 Apr; 26(4):355-60. PubMed ID: 2953987
[TBL] [Abstract][Full Text] [Related]
14. Locomotor bias produced by intra-accumbens injection of dopamine agonists and antagonists.
Messier C; Mrabet O; Destrade C
Pharmacol Biochem Behav; 1992 Jan; 41(1):177-82. PubMed ID: 1347172
[TBL] [Abstract][Full Text] [Related]
15. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
Hu XT; Brooderson RJ; White FJ
Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
[TBL] [Abstract][Full Text] [Related]
16. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
Giorgi O; Biggio G
Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
[TBL] [Abstract][Full Text] [Related]
17. Dopamine receptor subtypes and formalin test analgesia.
Morgan MJ; Franklin KB
Pharmacol Biochem Behav; 1991 Oct; 40(2):317-22. PubMed ID: 1687167
[TBL] [Abstract][Full Text] [Related]
18. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
Breese GR; Napier TC; Mueller RA
J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
[TBL] [Abstract][Full Text] [Related]
19. The effects of dopaminergic agonists and antagonists on the frequency-response function for hypothalamic self-stimulation in the rat.
Nakajima S; O'Regan NB
Pharmacol Biochem Behav; 1991 Jun; 39(2):465-8. PubMed ID: 1682950
[TBL] [Abstract][Full Text] [Related]
20. Relative dopamine D1 and D2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in rats.
Arnt J; Bøgesø KP; Hyttel J; Meier E
Pharmacol Toxicol; 1988 Mar; 62(3):121-30. PubMed ID: 3259694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
